Clinical Trial

Robotic Exoskeleton Assisted Gait Post Stroke

Study acronym: RE-Assist
Enrolling by Invitation Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The current investigation takes advantage of both a progressive and adaptive assist-as-needed massed practice and time-sensitive neuroplasticity through exoskeleton assisted walking in order to induce greater recovery-oriented CNS plasticity and consequent gains in more independent walking.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-03-12; most recent amendment 2025-04-02.
Trial Details
NCT Number NCT04309305
Lead Sponsor Kessler Foundation
Conditions CVA, Gait, Hemiplegic
Enrollment 75 participants
Start Date 2020-01-30
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-06